Pain Evaluation During Infancy Thru Adolescence: TReatment Impact and Considerations

Released On
March 1, 2022

Expires On
October 29, 2022

Media Type

Completion Time
60 minutes

Emergency Medicine, Hospitalist, Pain Management, Pediatrics, Primary Care, Psychiatry

Pain, Pediatrics

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by University of Kentucky HealthCare CECentral and The France Foundation.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Physician Assistants — 1.0 AAPA Category 1 CME credits
  • Nurses — 1.0 Contact Hours

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of physicians and other healthcare providers who are involved in the assessment and treatment of pain in children.

Program Overview

The Opioid Analgesic REMS is designed to ensure that the benefits of opioid analgesics outweigh the risks. The goal of this actvity is to address this need by providing education to the healthcare team on the treatment and monitoring or patients who are experiencing pain and who are younger than 18 years old.

Through education, the healthcare team will have an improved understanding of how to manage their pain and the role of opioid analgesics along with non-pharmacologic and non-opioid analgesics in pain management for pediatric patients. This activity will also provide information about the risks of opioids and use of other therapies, which is intended to assist HCPs in reducing adverse outcomes of addiction/substance use disorder, unintentional overdose, and death resulting from inappropriate prescribing and misuse of opioid analgesics.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Explain fundamental concepts of pain management, including definitions and mechanisms of pain
  • Assess patients with pain and identify potential risk factors for abuse and addiction
  • Describe the range of therapeutic options for managing pain, including non-pharmacologic approaches and pharmacologic (non-opioid and opioid analgesics) therapies
  • Integrate opioid analgesics into a pain treatment plan, individualized to meet the needs of the patient
  • Discuss safe and effective management of patients on opioid analgesics in the acute and chronic pain settings, including initiating therapy, titrating, and discontinuing use of opioid analgesics, if appropriate and necessary
  • Counsel patients and caregivers on the safe use of opioid analgesics, including proper storage and disposal
  • Counsel patients and caregivers about the use of naloxone for opioid overdose
  • Refer patients to a pain specialist, as appropriate
  • Describe the fundamental elements of addiction medicine
  • Identify and manage patients with opioid use disorders



Sarah Bagley, MD

Assistant Professor of Medicine and Pediatrics
Boston University School of Medicine
Boston, MA


Rebecca Loveless, MHS, DFAAPA, PA-C

Vituity Hospital Medicine
St. Louis, MO


Renee Manworren, PhD, RN-BC, APRN, PCNS-BC, AP-PMN, FAAN

Associate Professor of Pediatrics
Northwestern Medicine Feinberg School of Medicine Children’s Hospital
Chicago, IL

Joint Accreditation Statement

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

IPE Competencies

  • Roles/Responsibilities
  • Interprofessional Communication

Credit Designation

This enduring material is designated for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.


This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid through December 31, 2022.


The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

No speakers, authors, planners, or content reviewers have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures
  2. Participate in the online activity and attest that you have completed it
  3. Submit the evaluation form
  4. Claim CE Credit (CME, AAPA, CNE). Certificates will be emailed to the participant

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, or Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

University of Kentucky HealthCare CECentral and The France Foundation requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.


This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Contact Information

For CME questions please contact: